TUMORAD
LIVE

Serial Number

79183925

Owner

Spago Nanomedical AB

Filing Date

Dec 15, 2015

Add to watchlist:

No watchlists yet
View on USPTO

TUMORAD Trademark

Serial Number: 79183925 • Registration: 5043425

TUMORAD is a trademark filed by Spago Nanomedical AB on December 15, 2015. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Spago Nanomedical AB (2 trademarks)

Scheelevägen 2, Medicon Village,

Entity Type: 09

Trademark Details

Filing Date

December 15, 2015

Registration Date

September 20, 2016

Published for Opposition

July 5, 2016

Cancellation Date

December 16, 2025

Goods & Services

Chemicals used in industry and science; chemical reagents for scientific purposes; chemical reagents for non-medical purposes

Diagnostic preparations for medical or veterinary purposes; medical diagnostic reagents; x-ray contrast agents for medical purposes; radiological contrast substances for medical purposes; contrast media for use in medical imaging; anti-cancer preparations, namely, compounds for treating cancer; pharmaceutical preparations and products for the treatment of cancer; drug delivery agents in the form of nano-sized carriers that facilitate the delivery of pharmaceutical preparations, chemicals used in medicine and nanomedical applications, namely, chemical reagents for medical purposes and chemical preparations for pharmaceutical or medical purposes, namely, for treating cancer

Scientific and technological services and research and design relating thereto, namely, scientific, laboratory, and medical research in the nature of chemistry and nanoscale discovery research, scientific laboratory services, industrial research in the field of medical technology; medical analysis, namely, quality measurement and analysis for medical practices; medical research services; biotechnology research services; research and development in the area of nano-medicine, cancer treatment and cancer diagnostics

Filing History

DEATH OF INTERNATIONAL REGISTRATION
Jul 2, 2026 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Jan 7, 2024 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Dec 20, 2023 INTS
INVALIDATION PROCESSED
Dec 20, 2023 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 30, 2023 INTR
CANCELLED SECTION 71
Mar 31, 2023 C71T
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 15, 2017 FINO
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 14, 2017 OPNX
NEW REPRESENTATIVE AT IB RECEIVED
Apr 6, 2017 NREP
FINAL DISPOSITION NOTICE SENT TO IB
Feb 3, 2017 FICS
FINAL DISPOSITION PROCESSED
Feb 3, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 20, 2016 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 20, 2016 R.PR
PUBLISHED FOR OPPOSITION
Jul 5, 2016 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 15, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 15, 2016 OP2R
NOTICE OF PUBLICATION
Jun 15, 2016 NPUB
EXAMINERS AMENDMENT MAILED
Jun 2, 2016 CNEA
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 2, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 2, 2016 XAEC
EXAMINERS AMENDMENT -WRITTEN
Jun 2, 2016 CNEA
REFUSAL PROCESSED BY IB
May 14, 2016 RFNP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 10, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 10, 2016 REAP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 4, 2016 RFCS
REFUSAL PROCESSED BY MPU
Apr 4, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 3, 2016 RFCR
NON-FINAL ACTION WRITTEN
Apr 2, 2016 CNRT
ASSIGNED TO EXAMINER
Mar 31, 2016 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 15, 2016 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 10, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 3, 2016 REPR